Komori
Financial Results Presentation9267Genky DrugStores Co.,Ltd.Retail

Supplementary Materials for the Third Quarter of the Fiscal Year Ending June 2026

Revenue, operating profit and ordinary profit for the third quarter of the fiscal year ending June 2026 exceeded the year-earlier period, while net income declined slightly. The full-year forecast has been lowered from the initial ¥221.84 billion to ¥221.20 billion.

Worth reading
29Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
2212
¥100 million (updated full-year revenue forecast)
Wording
Definitive
How definitive the wording is.

Contents of this document

Supplementary materials to the earnings reportThird quarter of the fiscal year ending June 20262 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales52,866 Millions of yen+8.7%
Operating profit2,306 Millions of yen+2.8%
Ordinary income2,330 Millions of yen+0.3%
Net income1,600 Millions of yen-0.3%
Selling, general and administrative expenses8,393 Millions of yen
Gross Profit Margin
Rate20.24%
Operating profit margin
Rate4.4%
Results for the three months of the current quarter
Net Sales
52,866 Millions of yen
Operating profit
2,306 Millions of yen
Ordinary income
2,330 Millions of yen
Net income
1,600 Millions of yen
Full-year earnings forecast
Net Sales
221,200 Millions of yen
Gross profit
45,200 Millions of yen
Operating profit
11,050 Millions of yen
Ordinary income
11,200 Millions of yen
Net income
7,850 Millions of yen
What the company explained in this material
Key KPIsA metric the company considers important as a management benchmark.
  • Same-store sales (SSS)+1.8%
    Year on year against the same period last year+1.8%
  • Stores at Period End509 Location
Number of stores and locations
Number at period-end509 Location
Stores opened during the period9 Location
Store Closures During the Period0 Location
Stores renovated during the period0 Location
Contents of this document
ItemDetails
Document typeSupplementary materials to the earnings report
Fiscal Period CoveredThird quarter of the fiscal year ending June 2026
Net Sales52,866 Millions of yen (YoY +8.7%)
Operating profit2,306 Millions of yen (YoY +2.8%)
Ordinary income2,330 Millions of yen (YoY +0.3%)
Net income1,600 Millions of yen (YoY -0.3%)
Gross Profit MarginRate 20.24% / Year-on-year change (points) Not disclosed
Operating profit marginRate 4.4% / Year-on-year change (points) Not disclosed
Selling, general and administrative expenses8,393 Millions of yen
Results for the three months of the current quarterNet Sales 52,866 Millions of yen / Operating profit 2,306 Millions of yen / Ordinary income 2,330 Millions of yen / Net income 1,600 Millions of yen
Full-year earnings forecastNet Sales 221,200 Millions of yen / Gross profit 45,200 Millions of yen / Operating profit 11,050 Millions of yen / Ordinary income 11,200 Millions of yen / Net income 7,850 Millions of yen
Key KPIsIndicator name Same-store sales (SSS) / Value +1.8% / Year on year against the same period last year +1.8%, Indicator name Stores at Period End / Value 509 Location / Year on year against the same period last year Not disclosed
Number of stores and locationsNumber at period-end 509 Location / Stores opened during the period 9 Location / Store Closures During the Period 0 Location / Stores renovated during the period 0 Location
Items this document does not state (18)
Progress against full-year forecastSelf-assessment against the planSegment resultsBreakdown of Factors Affecting the ChangeUnit price and quantity metricsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&ANew initiatives

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The materials do not state the reason for changing the full-year forecast.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Supplementary Materials for the Third Quarter of the Fiscal Year Ending June 2026 | Genky DrugStores Co.,Ltd. (9267) timely disclosure | Komori